Long term follow up of celiac disease-Is atherosclerosis a problem?

Nutrients

Volumn 6, Issue 7, 2014, Pages 2718-2729

  Rybak, Anna ^a   Cukrowska, Bozena ^a   Socha, Jerzy ^a   Socha, Piotr ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Atherosclerosis; Celiac disease; Diabetes mellitus; Obesity

Indexed keywords

GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; CHOLESTEROL;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BACTEROIDES; BIFIDOBACTERIUM; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CHOLESTEROL BLOOD LEVEL; CONCURRENT INFECTION; ENTEROBACTERIACEAE; FOLLOW UP; GLUTEN FREE DIET; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LAMINA PROPRIA; NONHUMAN; NUTRITIONAL STATUS; REVIEW; RISK FACTOR; TH17 CELL; VITAMIN DEFICIENCY; BLOOD; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIET THERAPY; PATHOPHYSIOLOGY; PREVALENCE;

ATHEROSCLEROSIS; BODY MASS INDEX; CELIAC DISEASE; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIET, GLUTEN-FREE; HUMANS; NUTRITIONAL STATUS; PREVALENCE; RISK FACTORS;

EID: 84904615260     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6072718     Document Type: Review

References (67)

1. Dubé, C.; Rostom, A.; Sy, R.; Cranney, A.; Saloojee, N.; Garritty, C.; Sampson, M.; Zhang, L.; Yazdi, F.; Mamaladze, V.; et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology 2005, 128, S57-S67
2. Lohi, S.; Mustalahti, K.; Kaukinen, K.; Laurila, K.; Collin, P.; Rissanen, H.; Lohi, O.; Bravi, E.; Gasparin, M.; Reunanen, A.; et al. Increasing prevalence of coeliac disease over time. Aliment. Pharmacol. Ther. 2007, 26, 1217-1225.
3. Albrink, M.J.; Krauss, R.M.; Lindgrem, F.T.; von der Groeben, J.; Pan, S.; Wood, P.D. Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids 1980, 15, 668-676.
4. Zimmet, P.; Alberti, G.; Kaufman, F.; Tajima, N.; Silink, M.; Arslanian, S.; Wong, G.; Bennett, P.; Shaw, J.; Caprio, S.; et al. International diabetes federation task force on epidemiology and prevention of diabetes the metabolic syndrome in children and adolescents. Lancet 2007, 369, 2059-2061.
5. Alexopoulos, N.; Katritsis, D.; Raggi, P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis 2014, 233, 104-112.
6. Klünder-Klünder, M.; Flores-Huerta, S.; García-Macedo, R.; Peralta-Romero, J.; Cruz, M. Adiponectin in eutrophic and obesechildren as a biomarker to predict metabolic syndrome and each of its components. BMC Public Health 2013, 13, 88.
7. Sakuragi, S.; Abhayaratna, K.; Gravenmaker, K.J.; O'Reilly, C.; Srikusalanukul, W.; Budge, M.M.; Telford, R.D.; Abhayaratna, W.P. Influence of adiposity and physical activity on arterial stiffness in healthy children: The lifestyle of our kids study. Hypertension 2009, 53, 611-616.
8. West, J.; Logan, R.F.A.; Card, T.R.; Smith, C.; Hubbard, R. Risk of vascular disease in adults with diagnosed coeliac disease: A population-based study. Aliment. Pharmacol. Ther. 2004, 20, 73-79.
9. West, J.; Logan, R.F.A.; Hill, P.G.; Lloyd, A.; Lewis, S.; Hubbard, R.; Reader, R.; Holmes, G.K.T.; Khaw, K.-T. Seroprevalence, correlates, and characteristics of undetectedcoeliac disease in England. Gut 2003, 52, 960-965.
10. Ludvigsson, J.F.; West, J.; Card, T.; Appelros, P. Risk of stroke in 28,000 patients with celiac disease: A nationwide cohort study in Sweden. J. Stroke Cerebrovasc. Dis. 2012, 21, 860-867.
11. Qiao, S.-W.; Iversen, R.; Ráki, M.; Sollid, L.M. The adaptive immune response in celiac disease. Semin. Immunopathol. 2012, 34, 523-540.
12. Lammi, A.; Arikoski, P.; Vaarala, O.; Kinnunen, T.; Ilonen, J. Increased peripheral blood CD4+ T cell responses to deamidated but not to native gliadin in children with coeliac disease. Clin. Exp. Immunol. 2012, 168, 207-214.
13. Hansson, T.; Dannaeus, A.; Klareskog, L. Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile. Clin. Exp. Immunol. 1999, 116, 246-250.
14. Cybulsky, M.I.; Gimbrone, M.A., Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251, 788-791.
15. + T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102, 2919-2922.
16. Profumo, E.; Buttari, B.; Tosti, M.E.; Tagliani, A.; Capoano, R.; D'Amati, G.; Businaro, R.; Salvati, B.; Riganò, R. Plaque-infiltrating T lymphocytes in patientswith carotid atherosclerosis: An insight into the cellular mechanismsassociated to plaque destabilization. J. Cardiovasc. Surg. (Torino) 2013, 54, 349-357.
17. Erbel, C.; Dengler, T.J.; Wangler, S.; Lasitschka, F.; Bea, F.; Wambsganss, N.; Hakimi, M.; Böckler, D.; Katus, H.A.; Gleissner, C.A.; et al. Expression of IL-17A inhuman atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res. Cardiol. 2011, 106, 125-134.
18. Lim, H.; Kim, Y.U.; Sun, H.; Lee, J.H.; Reynolds, J.M.; Hanabuchi, S.; Wu, H.; Teng, B.-B.; Chung, Y. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 2014, 40, 153-165.
19. Lahdenperä, A.I.; Fälth-Magnusson, K.; Högberg, L.; Ludvigsson, J.; Vaarala, O. Expression pattern of T-helper 17 cell signaling pathway and mucosal inflammation in celiac disease. Scand. J. Gastroenterol. 2014, 49, 145-156.
20. Lahdenperä, A.; Ludvigsson, J.; Fälth-Magnusson, K.; Högberg, L.; Vaarala, O. The effect of gluten-free diet on Th1-Th2-Th3-associated intestinal immune responses in celiac disease. Scand. J. Gastroenterol. 2011, 46, 538-549.
21. Kverka, M.; Tlaskalova-Hogenova, H. Two faces ofmicrobiota in inflammatory and autoimmune diseases: Triggers and drugs. APMIS 2013, 121, 403-421.
22. Nadal, I.; Donat, E.; Donant, E.; Ribes-Koninckx, C.; Calabuig, M.; Sanz, Y. Imbalance in the composition of the duodenal microbiota ofchildren with coeliac disease. J. Med. Microbiol. 2007, 56, 1669-1674.
23. De Palma, G.; Kamanova, J.; Cinova, J.; Olivares, M.; Drasarova, H.; Tuckova, L.; Sanz, Y. Modulation of phenotypic and functional maturation ofdendritic cells by intestinal bacteria and gliadin: Relevance for celiac disease. J. Leukoc. Biol. 2012, 92, 1043-1054.
24. Karlsson, F.; Tremaroli, V.; Nielsen, J.; Bäckhed, F. Assessing the Human Gut Microbiota in Metabolic Diseases. Diabetes 2013, 62, 3341-3349.
25. Karlsson, F.H.; Fåk, F.; Nookaew, I.; Tremaroli, V.; Fagerberg, B.; Petranovic, D.; Bäckhed, F.; Nielsen, J. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 2012, 3, 1245.
26. Holvoet, P.; Mertens, A.; Verhamme, P.; Bogaerts, K.; Beyens, G.; Verhaeghe, R.; Collen, D.; Muls, E.; van de Werf, F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 844-848.
27. Ciccocioppo, R.; di Sabatino, A.; Corazza, G.R. The immune recognition of gluten in coeliac disease. Clin. Exp. Immunol. 2005, 140, 408-416.
28. Zimmer, K.-P.; Fischer, I.; Mothes, T.; Weissen-Plenz, G.; Schmitz, M.; Wieser, H.; Büning, J.; Lerch, M.M.; Ciclitira, P.C.; Weber, P.; et al. Endocytotic segregation of gliadin peptide 31-49 in enterocytes. Gut 2010, 59, 300-310.
29. Ferretti, G.; Bacchetti, T.; Masciangelo, S.; Saturni, L. Celiac disease, inflammation and oxidative damage: A nutrigenetic approach. Nutrients 2012, 4, 243-257.
30. Fasano, A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005, 128, 68-73.
31. Garampazzi, A.; Rapa, A.; Mura, S.; Capelli, A.; Valori, A.; Boldorini, R.; Oderda, G. Clinical pattern of celiac disease is still changing. J. Pediatr. Gastroenterol. Nutr. 2007, 45, 611-614.
32. Dickey, W.; Bodkin, S. Prospective study of body mass index in patients with coeliac disease. BMJ 1998, 317, 1290.
33. Dickey, W.; Kearney, N. Overweightin celiac disease: Prevalence, clinical characteristics, and effect of a gluten-free diet. Am. J. Gastroenterol. 2006, 101, 2356-2359.
34. Ukkola, A.; Mäki, M.; Kurppa, K.; Collin, P.; Huhtala, H.; Kekkonen, L.; Kaukinen, K. Changes in body mass index on a gluten-free dietin coeliac disease: A nationwide study. Eur. J. Intern. Med. 2012, 23, 384-388.
35. Tucker, E.; Rostami, K.; Prabhakaran, S.; Al Dulaimi, D. Patients with coeliac disease are increasingly overweight orobese on presentation. J. Gastrointest. Liver Dis. 2012, 21, 11-15.
36. Kabbani, T.A.; Goldberg, A.; Kelly, C.P.; Pallav, K.; Tariq, S.; Peer, A.; Hansen, J.; Dennis, M.; Leffler, D.A. Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment. Pharmacol. Ther. 2012, 35, 723-729.
37. Cheng, J.; Brar, P.S.; Lee, A.R.; Green, P.H.R. Body mass index in celiac disease: Beneficial effect of a gluten-free diet. J. Clin. Gastroenterol. 2010, 44, 267-271.
38. Wierdsma, N.J.; van Bokhorst-de van der Schueren, M.A.E.; Berkenpas, M.; Mulder, C.J.J.; van Bodegraven, A.A. Vitamin and Mineral Deficiencies Are Highly Prevalent in Newly Diagnosed Celiac Disease Patients. Nutrients 2013, 5, 3975-3992.
39. Aurangzeb, B.; Leach, S.T.; Lemberg, D.A.; Day, A.S. Nutritional status of children with coeliac disease. Acta Paediatr. 2010, 99, 1020-1025.
40. Brambilla, P.; Picca, M.; Dilillo, D.; Meneghin, F.; Cravidi, C.; Tischer, M.C.; Vivaldo, T.; Bedogni, G.; Zuccotti, G.V. Changes of body mass index in celiac children on a gluten-free diet. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 177-182.
41. Diamanti, A.; Capriati, T.; Basso, M.S.; Panetta, F.; di Ciommo Laurora, V.M.; Bellucci, F.; Cristofori, F.; Francavilla, R. Celiac Disease and Overweight in Children: An Update. Nutrients 2014, 6, 207-220.
42. Kabbani, T.A.; Kelly, C.P.; Betensky, R.A.; Hansen, J.; Pallav, K.; Villafuerte-Galvez, J.A.; Vanga, R.; Mukherjee, R.; Novero, A.; Dennis, M.; et al. Patients with Celiac Disease Have a Lower Prevalence of Non-Insulin-Dependent Diabetes Mellitus and Metabolic Syndrome. Gastroenterology 2013, 144, 912-917. e1.
43. Mariani, P.; Viti, M.G.; Montuori, M.; la Vecchia, A.; Cipolletta, E.; Calvani, L.; Bonamico, M. The gluten-free diet: A nutritional risk factor for adolescents with celiac disease? J. Pediatr. Gastroenterol. Nutr. 1998, 27, 519-523.
44. Rea, F.; Polito, C.; Marotta, A.; di Toro, A.; Iovene, A.; Collini, R.; Rea, L.; Sessa, G. Restoration of body composition in celiac children after one yearof gluten-free diet. J. Pediatr. Gastroenterol. Nutr. 1996, 23, 408-412.
45. Zanini, B.; Mazzoncini, E.; Lanzarotto, F.; Ricci, C.; Cesana, B.M.; Villanacci, V.; Lanzini, A. Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. Dig. Liver Dis. 2013, 45, 810-815.
46. Martin, J.; Geisel, T.; Maresch, C.; Krieger, K.; Stein, J. Inadequate nutrient intake in patients with celiac disease: Results from a german dietary survey. Digestion 2013, 87, 240-246.
47. Sategna-Guidetti, C.; Grosso, S.B.; Grosso, S.; Mengozzi, G.; Aimo, G.; Zaccaria, T.; di Stefano, M.; Isaia, G.C. The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosedadult coeliac disease patients. Aliment. Pharmacol. Ther. 2000, 14, 35-43.
48. Bardella, M.T.; Fredella, C.; Prampolini, L.; Molteni, N.; Giunta, A.M.; Bianchi, P.A. Body composition and dietary intakes in adult celiac disease patients consuming a strict gluten-free diet. Am. J. Clin. Nutr. 2000, 72, 937-939.
49. Hallert, C.; Grant, C.; Grehn, S.; Grännö, C.; Hultén, S.; Midhagen, G.; Ström, M.; Svensson, H.; Valdimarsson, T. Evidence ofpoor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment. Pharmacol. Ther. 2002, 16, 1333-1339.
50. Dietrich, M.; Brown, C.J.P.; Block, G. The effect offolate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J. Am. Coll. Nutr. 2005, 24, 266-274.
51. Thompson, T. Folate, iron, and dietary fiber contents of the gluten-free diet. J. Am. Diet. Assoc. 2000, 100, 1389-1396.
52. De Marchi, S.; Chiarioni, G.; Prior, M.; Arosio, E. Young adults with coeliac disease may be at increased risk of early atherosclerosis. Aliment. Pharmacol. Ther. 2013, 38, 162-169.
53. Braegger, C.; Campoy, C.; Colomb, V.; Decsi, T.; Domellof, M.; Fewtrell, M.; Hojsak, I.; Mihatsch, W.; Molgaard, C.; Shamir, R.; et al. ESPGHAN Committee on Nutrition Vitamin D in the healthy Europeanpaediatric population. J. Pediatr. Gastroenterol. Nutr. 2013, 56, 692-701.
54. Soares, F.L.P.; de Oliveira Matoso, R.; Teixeira, L.G.; Menezes, Z.; Pereira, S.S.; Alves, A.C.; Batista, N.V.; de Faria, A.M.C.; Cara, D.C.; Ferreira, A.V.M.; et al. Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression. J. Nutr. Biochem. 2013, 24, 1105-1111.
55. Godfrey, J.D.; Brantner, T.L.; Brinjikji, W.; Christensen, K.N.; Brogan, D.L.; van Dyke, C.T.; Lahr, B.D.; Larson, J.J.; Rubio-Tapia, A.; Melton, L.J.; et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010, 139, 763-769.
56. Ciacci, C.; Cirillo, M.; Giorgetti, G.; Alfinito, F.; Franchi, A.; Mazzetti di Pietralata, M.; Mazzacca, G. Low plasma cholesterol: A correlate of nondiagnosed celiac disease in adults with hypochromic anemia. Am. J. Gastroenterol. 1999, 94, 1888-1891.
57. Vuoristo, M.; Miettinen, T.A. Increased biliary lipid secretion in celiac disease. Gastroenterology 1985, 88, 134-142.
58. Lewis, N.R.; Sanders, D.S.; Logan, R.F.A.; Fleming, K.M.; Hubbard, R.B.; West, J. Cholesterol profile in people with newly diagnosed coeliac disease: A comparison with the general population and changes following treatment. Br. J. Nutr. 2009, 102, 509-513.
59. Brar, P.; Kwon, G.Y.; Holleran, S.; Bai, D.; Tall, A.R.; Ramakrishnan, R.; Green, P.H.R. Change in lipid profile in celiac disease: Beneficial effect of gluten-free diet. Am. J. Med. 2006, 119, 786-790.
60. Smyth, D.J.; Plagnol, V.; Walker, N.M.; Cooper, J.D.; Downes, K.; Yang, J.H.M.; Howson, J.M.M.; Stevens, H.; McManus, R.; Wijmenga, C.; et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 2008, 359, 2767-2777.
61. Gutierrez-Achury, J.; Coutinho de Almeida, R.; Wijmenga, C. Shared genetics in coeliac disease and other immune-mediated diseases. J. Intern. Med. 2011, 269, 591-603.
62. McVeigh, G.E.; Gibson, W.; Hamilton, P.K. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk ofcardiovascular disease. Diabetes Obes. Metab. 2013, 15, 198-203.
63. Pitocco, D.; Giubilato, S.; Martini, F.; Zaccardi, F.; Pazzano, V.; Manto, A.; Cammarota, G.; di Stasio, E.; Pedicino, D.; Liuzzo, G.; et al. Combined atherogenic effects of celiac disease and type 1 diabetes mellitus. Atherosclerosis 2011, 217, 531-535.
64. Picarelli, A.; di Tola, M.; Sabbatella, L.; Mercuri, V.; Pietrobono, D.; Bassotti, G.; D'Amico, T.; Donato, G.; Picarelli, G.; Marino, M.; et al. Type 1 diabetes mellitus and celiac disease: Endothelial dysfunction. Acta Diabetol. 2013, 50, 497-503.
65. Leeds, J.S.; Hopper, A.D.; Hadjivassiliou, M.; Tesfaye, S.; Sanders, D.S. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011, 34, 2158-2163.
66. Taler, I.; Phillip, M.; Lebenthal, Y.; de Vries, L.; Shamir, R.; Shalitin, S. Growth and metabolic control in patients with type 1 diabetes and celiac disease:a longitudinal observational case-control study. Pediatr Diabetes 2012, 13, 597-606.
67. Valerio, G.; Maiuri, L.; Troncone, R.; Buono, P.; Lombardi, F.; Palmieri, R.; Franzese, A. Severe clinical onset of diabetes and increased prevalenceof other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia 2002, 45, 1719-1722